Research Appraisalother

Comparative analysis of key phagocytic genes in humans and mice using machine learning integrated with single-cell RNA sequencing

NeuroscienceChengcheng, Li, Hang, Liu6 Apr 2026DOI

Clinical Snapshot

75CEBM
Evidence: Moderateother

PICO Framework

P — PopulationMurine and human microglia from intracerebral hemorrhage (ICH) models/samples
I — InterventionSingle-cell RNA sequencing analysis with machine learning (XGBoost) integration
C — ComparatorSpecies comparison (mice vs humans) and temporal analysis of microglial responses
O — OutcomesIdentification of phagocytosis-associated genes (Tlr2 in mice, CLEC7A in humans), transcription factor activity patterns, and species-specific microglial responses

Bottom Line

This comparative molecular study reveals important species differences in microglial responses following intracerebral hemorrhage, with mice showing sustained phagocytic enhancement while humans exhibit transient activation followed by persistent inflammation. The identification of Tlr2 in mice and CLEC7A in humans as key phagocytosis-associated genes provides potential therapeutic targets. However, the clinical translation is limited by lack of statistical validation, unclear human sample characteristics, and absence of functional studies. While the machine learning integration with single-cell RNA sequencing represents a methodological advance, clinicians should interpret these findings cautiously pending validation studies. The work highlights the critical importance of considering species differences when translating preclinical stroke research to human therapeutics.

Evidence: Moderate

Key Findings

  • P Value: Not reported

  • Effect Size: Not quantified - qualitative gene expression differences reported

  • Primary Outcome: Species-specific identification of phagocytosis-associated genes: Tlr2 in mice and CLEC7A in humans

  • Nnt Or Sensitivity: XGBoost model selected as best-performing among five machine learning approaches

  • Confidence Interval: Not reported

Clinical Application

Requires specialized single-cell sequencing facilities and bioinformatics expertise; not immediately applicable to routine clinical practice Relevant to Australian stroke units and neurocritical care; may inform future TGA submissions for microglial-targeted therapeutics; aligns with NHMRC precision medicine initiatives Patients with intracerebral hemorrhage, particularly those being considered for microglial-targeted therapies

Abstract

Microglial phagocytosis is essential for neurological recovery after intracerebral hemorrhage (ICH). Using single-cell RNA sequencing, we compared microglial responses in murine and human ICH and identified striking species-specific temporal patterns. Murine microglia exhibited a sustained enhancement of phagocytic activity, whereas human microglia showed only a transient increase followed by a decline and persistent inflammation. To identify genes associated with phagocytic differences, we evaluated five machine learning models and selected XGBoost as the best-performing model. This analysis identified Tlr2 in mice and CLEC7A in humans as genes associated with microglial phagocytic status. Inferred transcription factor activity analysis further revealed stronger phagocytosis- and inflammation-associated transcriptional activity in murine phagocytic microglial subclusters, whereas human microglia were predominantly characterized by inflammation-associated transcription factors. Consistent with these results, Tlr2 expression was markedly increased at day 14 in single-cell data, and immunostaining confirmed its colocalization with IBA1+ microglia and upregulation at days 3 and 7 after ICH. Together, our findings demonstrate that integrating single-cell RNA sequencing with machine learning facilitates the identification of phagocytosis-associated genes and reveals both conserved and divergent patterns of microglial phagocytosis, providing new insights into species-specific responses to ICH.

Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service